Appointment Changes at Cincinnati Children's

During the national health emergency, routine follow-up appointments for established patients are being reviewed and may be rescheduled for a later date. You will be contacted if these changes affect your child. If you have questions for your clinical team, contact them via MyChart.


To our patients who had appointments at any of our Allergy and Immunology clinics: We sincerely apologize for having to cancel your appointments at our clinics. While we were looking forward to seeing you and evaluating your child, this step was necessary to protect you and your child due to the COVID-19 pandemic. We are working on performing visits through a phone contact or video contact (telemedicine). We will be contacting you with further details and to assess your willingness to have the visit conducted remotely. Please be assured that all cancelled visits will be rescheduled as soon as the situation allows.

Allergen Immunotherapy

To our patients who are receiving allergen immunotherapy (also known as allergy shots) at any of our Allergy / Immunology clinics: The Division of Allergy and Immunology knows the value of this important treatment to your child. However, in an effort to contain the spread of the COVID-19 pandemic and to protect you and your child, we have halted all administration of allergy shots till further notice. Please be assured that your allergist will work with you on adjusting treatment once the clinics are able to be resumed safely.

Asthma and Allergies

  • Asthma exacerbations are frequently triggered by viral infections, including coronaviruses. But coronaviruses are not common triggers compared with other viruses (such as rhinovirus, respiratory syncytial virus, adenovirus, herpes simplex virus, enterovirus, and influenza virus).
  • People with moderate to severe asthma may be at higher risk of getting very sick from COVID-19.  COVID-19 can affect your respiratory tract (nose, throat, lungs), cause an asthma attack, and possibly lead to pneumonia and acute respiratory disease. Read more from the CDC


  • Patients in research studies should make personal decisions about the risk / reward of continuing to participate and adhere to local and national health department guidelines regarding travel and preparedness.
  • Subjects with concurrent viral-like illnesses should reschedule their study visits.
  • If you have specific questions regarding your trial related to the known risks of the COVID-19 virus, contact your specific research trial team.